Predictive factors for pituitary response to pulsatile GnRH therapy in patients with congenital hypo

来源 :亚洲男性学杂志(英文版) | 被引量 : 0次 | 上传用户:zilong2006min
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Pulsatile gonadotropin-releasing hormone (GnRH) may induce spermatogenesis in most patients with congenital hypogonadotropic hypogonadism (CHH) by stimulating gonadotropin production,while the predictors for a pituitary response to pulsatile GnRH therapy were rarely investigated.Therefore,the aim of our study is to investigate predictors of the pituitary response to pulsatile GnRH therapy.This retrospective cohort study included 82 CHH patients who received subcutaneous pulsatile GnRH therapy for at least 1 month.Patients were categorized into poor or normal luteinizing hormone (LH) response subgroups according to their LH level (LH <2 IU I-1 or LH ≥2 IU I-1) 1 month into pulsatile GnRH therapy.Gonadotropin and testosterone levels,testicular size,and sperm count were compared between the two subgroups before and after GnRH therapy.Among all patients,LH increased from 0.4 ± 0.5 IU I-1 to 7.5 ± 4.4 IU I-1 and follicle-stimulating hormone (FSH) increased from 1.1 ± 0.9 IU I-1 to 8.8 ± 5.3 IU I-1.A Cox regression analysis showed that basal testosterone level (β =0.252,P =0.029) and triptorelin-stimulated FSH6omin (β =0.518,P=0.01) were two favorable predictors for pituitary response to GnRH therapy.Nine patients (9/82,11.0%) with low LH response to GnRH therapy were classified into the poor LH response subgroup.After pulsatile GnRH therapy,total serum testosterone level was 39 ± 28 ng dl-1 versus 248 ± 158 ng dl-1 (P =0.001),and testicular size was 4.0 ± 3.1 ml versus 7.9 ± 4.5 ml (P =0.005)in the poor and normal LH response subgroups,respectively.It is concluded that higher levels of triptorelin-stimulated FSH60min and basal total serum testosterone are favorable predictors of pituitary LH response to GnRH therapy.
其他文献
期刊
Epidemiological studies hint at a beneficial influence of endogenous circulating testosterone (T), or its metabolite dihydrotestosterone (DHT),such that men with lower concentrations of T or DHT appear to have poorer health outcomes including frailty, dia
期刊
Spermatozoa retrieved from the testis of men with high levels of sperm DNA fragmentation (SDF) in the neat semen tend to have better DNA quality. Given the negative impact of SDF on the outcomes of Assisted Reproductive Technology (ART), an increased inte
期刊
The last decade has seen remarkable advances in the treatment of prostate cancer.Until 2010,only docetaxel had demonstrated the ability to improve the survival in metastatic castration-resistant prostate cancer (mCRPC).1 While effective,many men were relu
期刊
Male hypogonadism associated with obesity is a very prevalent condition and is increasing in parallel with the epidemic prevalence of obesity.Low testosterone levels promote higher fat mass with reduced lean mass.Male hypogonadism is related to an increas